Genome Editing: Continuity or Disruption of Existing Biotechnology Regime?
Speaker(s):
Dr. Michael Morrison, HeLEX: Centre for Health, Law and Emerging Technologies, University of Oxford
Series:
Future of Technology and Society Discussion Group
Associated with:
Notes & Changes
Please contact Beril Boz by 2 December 2020 to register.
Add to calendar
In this session we will be joined by Dr. Michael Morrison of HeLEX: Centre for Health, Law and Emerging Technologies. Dr. Morrison will open the discussion on the following topics:
- Introduction to Genome Editing
- Regulatory and Cultural Impacts over the Development of this Technology
Suggested readings:
- Martin, Morrison, et al, 'Genome Editing: the Dynamics of Continuity, Convergence, and Change in the Engineering of Life', 39:2 New Genetics and Society, 219-242
- Heidi Ledford, 'CRISPR, the Disruptor', Nature (4 June 2015)
- Mourby and Morrison, 'Gene Therapy Regulation: Could In-body Editing Fall Through the Net?', 28 European Journal of Human Genetics, 979-981
Theme:
General Interest
